SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 58 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $632,000 | -65.7% | 65,000 | -48.0% | 0.12% | -61.7% |
| Q3 2017 | $1,840,000 | -6.0% | 125,000 | +2.8% | 0.32% | -7.2% |
| Q2 2017 | $1,957,000 | +29.3% | 121,624 | +27.9% | 0.35% | +143.7% |
| Q1 2017 | $1,514,000 | +161.9% | 95,100 | +100.0% | 0.14% | +25.7% |
| Q4 2016 | $578,000 | -12.4% | 47,550 | 0.0% | 0.11% | -6.6% |
| Q3 2016 | $660,000 | – | 47,550 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |